1. Home
  2. HCA vs SNPS Comparison

HCA vs SNPS Comparison

Compare HCA & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCA Healthcare Inc.

HCA

HCA Healthcare Inc.

HOLD

Current Price

$372.17

Market Cap

105.5B

Sector

Health Care

ML Signal

HOLD

Logo Synopsys Inc.

SNPS

Synopsys Inc.

HOLD

Current Price

$463.62

Market Cap

96.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCA
SNPS
Founded
1968
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
105.5B
96.6B
IPO Year
2009
1994

Fundamental Metrics

Financial Performance
Metric
HCA
SNPS
Price
$372.17
$463.62
Analyst Decision
Buy
Buy
Analyst Count
20
14
Target Price
$511.84
$540.71
AVG Volume (30 Days)
1.5M
1.7M
Earning Date
04-24-2026
05-27-2026
Dividend Yield
0.72%
N/A
EPS Growth
28.77
N/A
EPS
7.15
0.43
Revenue
$75,600,000,000.00
$5,081,542,000.00
Revenue This Year
$5.11
$39.22
Revenue Next Year
$4.86
$10.73
P/E Ratio
$50.64
$1,149.09
Revenue Growth
7.08
20.87
52 Week Low
$330.00
$376.18
52 Week High
$556.52
$651.65

Technical Indicators

Market Signals
Indicator
HCA
SNPS
Relative Strength Index (RSI) 26.15 39.54
Support Level N/A $442.25
Resistance Level $483.20 $488.81
Average True Range (ATR) 10.18 20.86
MACD -1.18 -6.22
Stochastic Oscillator 16.66 0.54

Price Performance

Historical Comparison
HCA
SNPS

About HCA HCA Healthcare Inc.

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Share on Social Networks: